Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Sep;10(3):213-21.
doi: 10.1076/ocii.10.3.213.15598.

A long-term follow-up of Eales' disease

Affiliations

A long-term follow-up of Eales' disease

Leyla S Atmaca et al. Ocul Immunol Inflamm. 2002 Sep.

Abstract

Purpose: To provide long-term follow-up information on Eales' patients.

Methods: Eales' patients, who had been examined at varying periods between the years 1970 and 1991 with a minimum five-year follow-up, were included in the study.

Results: A total of 130 patients were followed up for a minimum of five and a maximum of 26.5 years. The retinal lesions found during the first examination included vascular sheathing, disc and/or retinal neovascularization, vitreous hemorrhage, branch retinal vein occlusion, retinitis proliferans, and retinal detachment. Visual acuity improved in 37 (20%) of the 185 treated eyes, was maintained in 79 (43%), and worsened in 69 (37%). The complications were tractional detachment, cataract, rubeosis iridis, neovascular glaucoma, and phthisis bulbi.

Conclusion: The most important elements in dealing with Eales' disease are periodic follow-up, a good and adequate laser treatment, pars plana vitrectomy combined with procedures for nonclearing vitreous hemorrhage, and retinal vasoproliferative changes to stabilize the retinal lesions and maintain functional levels of vision.

PubMed Disclaimer

Comment in

  • A long term follow up to Eale's disease.
    Biswas J, Shanmugam M. Biswas J, et al. Ocul Immunol Inflamm. 2004 Sep;12(3):247-8; author reply 249. doi: 10.1080/09273940490883743. Ocul Immunol Inflamm. 2004. PMID: 15385202 No abstract available.

MeSH terms

LinkOut - more resources